Wedbush Increases Price Target On Centene To $39

According to Wedbush, Centene CNC estimates are increased. Wedbush said that it is raising its 2012 estimate $0.21, to $2.68, and increasing its price target to $39 from $38. “Our increased estimates reflect the recent Medicaid Expansion win in Kentucky which we believe could add $0.17-$0.25 on an annualized basis.” Centene closed yesterday at $36.14.